Search
Patexia Contest

CONTEST

Competed

5-aminosalicylates for Antibacterial Use

Evidence of Use
Prize
$3,000
DEADLINE
This contest is closed.
Winner

Not Disclosed

technology
Winner

Govindhaswamy Srinivasan

technology
Runner Up

Padmini anbalagan

technology
Runner Up

Sindhia Rani

technology

Problem

Patexia would like to disseminate the innovation of using 5-aminosalicylate or related compounds (see below) as an antibacterial agent. To enter this contest, find a source demonstrating commercial uses of a compound containing 5-aminosalicylates for the purpose of preventing or inhibiting bacterial growth in humans, dated after February 8th, 1999. Sources must demonstrate use by a commercial entity, and may be in the form of clinical trials, FDA filings, product inserts or advertisements, orange book entries, or other similar documentation.

The following questions will help clarify the contest and eligible submissions. To be eligible for full prize amount, users should answer “yes” to at least questions 1 and 2. Additional questions will be used to determine a contest winner amongst multiple entries. Between multiple entries answering the same questions, the first complete submission will be selected.

  1. Does the source document a commercial use after February 8th, 1999?
  2. Does it describe the use of 5-aminosalicylate (or related compounds, see below for list) to inhibit the growth of bacterial species in humans?
  3. Is this use in the human digestive tract?
  4. Is the bacteria a member of the clostridium species (e.g. perfringens, difficile, tetani, botulinum)?
  5. Is the 5-aminosalicylate compound delivered systematically (colonic, ingestive, topical, etc.)?
  6. Is it delivered non-systematically (ingestion, injection, IV drip, implant, transdermal, transmucosal)?
Have a question about this contest? Ask a Question

Questions

#QuestionValue
1Does the source document a commercial use after February 8th, 1999? 0
2Does it describe the use of 5-aminosalicylate (or related compounds, see below for list) to inhibit the growth of bacterial species in humans? 0
3Is this use in the human digestive tract? 0
4Is the bacteria a member of the clostridium species (e.g. perfringens, difficile, tetani, botulinum)? 0
5Is the 5-aminosalicylate compound delivered systematically (colonic, ingestive, topical, etc.)? 0
6Is it delivered non-systematically (ingestion, injection, IV drip, implant, transdermal, transmucosal)? 0

Additional Notes

  • This use of 5-aminosalicylate is described in US patent 6,326,364 - “Use of 5-aminosalicylates as antimicrobial agents.”
  • Submission deadline is February 20, 2013
  • All work must be prepared by a single researcher
  • Maximum of one entry per person allowed
  • Entries must be in English. In case you are submitting foreign references, please provide a translation of key sections.
  • If you were referred, the referral prize ($500) will be paid to the referring user from the total prize pool of $3000.
  • Please make sure to answer all the questions and explain how we can find that in the reference
  • If your reference has already been submitted by another researcher before you or is among the known references, it will not be considered for the contest.
  • Please use “Ask a Question” to post general questions or feedback about the contest to the community.
  • For specific questions, you can contact us directly by email at contests@patexia.com
  • All submissions are subject to Patexia's contest legal terms. Failure to follow these rules may lead to disqualification from the contest


Related compounds containing 5-aminosalicylates:

  • 5-aminosalicylatic acid [a.k.a. mesalamine]
  • any compound containing a 5-aminosalicylate or 5-aminosalicylatic acid moiety
  • 5-aminosalicylate salts (sodium or potassium salts of conjugated 5-aminosalicylates)
  • olsalazine or Poly-ASA [a.k.a disodium-diazosalicylate, azodisalicylate, or Dipentum® (Pharmacia)]
  • balsalazide [a.k.a. balsalazine]
  • sulphasalazine [a.k.a. sulfasalazine, salazosulfapyridine, or Azulfidine®)
  • ipsalazine [a.k.a. ipsalazide]
  • salicylazobenzoic acid
  • ursodeoxycholic acid-5-aminosalicylic acid

Commercial compounds containing 5-aminosalicylates:

  • Asacol® (P&G)
  • Pentasa® (Ferring A/S Vanlose)
  • Claversal®
  • Mesasal®
  • Rowasa®
  • Salofalk® (Dr. Falk GmbH)
Menu